Noom members continued losing weight a year after program ended
In a 68-week trial, Noom participants lost an average of 4.1% body weight at week 68, while controls gained 1.5%.
See the latest news and media coverage for Noom. We track all announcements, press releases, and industry mentions in real time, all in one place.
Psychology-based weight loss program
noom.comLast updated
In short: Noom expanded its metabolic health offerings through new biomarker testing, compounding pharmacy acquisition, and long-term weight loss clinical data.
In a 68-week trial, Noom participants lost an average of 4.1% body weight at week 68, while controls gained 1.5%.
The kit measures cardiovascular, metabolic, hormonal, and nutritional markers, enabling members to track health improvements from home.
SmartRx bypasses PBMs and projects ~$1.3M annual spend versus $6.2M prior year for its first employer, integrating behavior change with medication access.
The feature lets Medicare members connect medical records to personalize Noom's diabetes and obesity programs.
Peer-reviewed randomized controlled trial of 427 adults found that after completing Noom’s 16-week program, members continued losing weight for the next 52 weeks — reaching...
New data shows widespread undetected metabolic risk - even among 'healthy” individuals - as Noom enables members to test, treat, and track progress from home...
Highmark will start covering Noom — a subscription-based app that claims to enable weight loss by harnessing psychological research — at no cost for nearly...
Popular digital weight loss app,Noom (NOOM) undercuts Novo Nordisk's (NYSE:NVO) Wegovy by offering...
Track Noom and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Noom and other trending companies.